PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
22-Oct-2024 NICE recommends Voydeya® (danicopan) with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria (PNH) in adults with residual haemolytic anaemia AstraZeneca
22-Oct-2024 Innovative Trials in running for industry award in recognizing efforts to improve patient outcomes Innovative Trials
22-Oct-2024 ACI Group offers digital solutions as BCI report highlights widespread supply chain chaos ACI Group
22-Oct-2024 Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024 Vivet Therapeutics
22-Oct-2024 Ariceum Therapeutics Presents Outstanding Data on its First-in-Class Radiopharmaceutical Drug 225Ac-Satoreotide at the European Association of Nuclear Medicine 2024 Ariceum Therapeutics (Ariceum)
22-Oct-2024 Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis AstraZeneca
22-Oct-2024 Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi
22-Oct-2024 Fixing NHS needs greater investment in medicines, says ABPI Association of the British Pharmaceutical Industry (ABPI)
22-Oct-2024 ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman ONWARD Medical
18-Oct-2024 Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials Medidata
18-Oct-2024 Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress Biognosys
18-Oct-2024 Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024 Medigene AG
18-Oct-2024 Fortrea Releases Inaugural Corporate Social Responsibility Report Fortrea
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Inc
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi
18-Oct-2024 PUBLICATION DEMONSTRATES POTENTIAL FOR MULTI-MARKER CTC PROFILING IN EARLY PROSTATE CANCER ANGLE plc
18-Oct-2024 Yourgene Health Cystic Fibrosis Base Assay Receives IVDR Accreditation Yourgene Health
18-Oct-2024 SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878 SciRhom GmbH
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi and Orano Med
18-Oct-2024 EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries EVERSANA